C-reactive protein: A surrogate marker for atherosclerosis

Current Opinion in Lipidology

Volumn 15, Issue 3, 2004, Pages 365-367

  Davidson, Jillian ^a   Rotondo, Dino ^a  

^a UNIVERSITY OF STRATHCLYDE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; C REACTIVE PROTEIN;

ATHEROGENESIS; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; DISEASE COURSE; DISEASE MARKER; EDITORIAL; HUMAN; LIPID PEROXIDATION; MEASUREMENT; PATHOGENESIS; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ANIMALS; ARTERIOSCLEROSIS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; ENDOTHELIUM, VASCULAR; EPOPROSTENOL; INFLAMMATION; NITRIC OXIDE; RATS;

EID: 2642572887     PISSN: 09579672     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041433-200406000-00019     Document Type: Editorial

References (10)

1. Phillips H. Heart-stopping. New Scientist, 11 January 2003; 36-39.
2. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000; 342:836-843.
3. Arenillas JF, Alvarez-Sabin J, Molina CA, et al. C-reactive protein predicts further ischemic events in first-ever transient ischemic attack or stroke patients with intracranial large-artery occlusive disease. Stroke 2003; 34:2463-2470.
4. Jabs JW, Theissing E, Nitschkle M, et al. Local generation of C-reactive protein in diseased coronary artery venous bypass grafts and normal vascular tone. Circulation 2003; 108:1428-1431.
5. Blake GJ, Ridker PM. C-reactive protein: a surrogate risk marker or mediator of atherothrombosis. Am J Physiol Regul Integr Comp Physiol 2003; 285:R1250-R1252.
6. Verma S, Yeh ETH. C-reactive protein and atherothrombosis: beyond a biomarker: an actual partaker of lesion formation. Am J Physiol Regul Integr Comp Physiol 2003; 285:R1253-R1256.
7. Venugopal SK, Devaraj S, Yuhanna I, et al. Demonstration that C-reactive protein decreases eNOS expression and bioactivity in human aortic endothelial cells. Circulation 2002; 106:1439-1441.
8. Venugopal SK, Devaraj S, Jialal I. C-reactive protein decreases prostacyclin release from human aortic endothelial cells. Circulation 2003; 108:1676-1678.
9. Ikeda U, Takahashi M, Shimada K. C-reactive protein directly inhibits nitric oxide production by cytokine-stimulated vascular smooth muscle cells. J Cardiovasc Pharmacol 2003; 42:607-611.
10. Baskin Y, Baskin H, Guner G, et al. The inversely proportional relation between nitric oxide and lipid peroxidation in atherosclerotic plaque formation in human. Int J Cardiol 2003; 91:43-51.